Skip to content

Assessing the safety and value of shortened heart ultrasound scan protocols

The clinical utility of an abbreviated echocardiography protocol for the echocardiographic assessment of outpatients with aortic stenosis and inpatients post-acute coronary syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN13024576
Enrollment
354
Registered
2026-07-27
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic stenosis and acute coronary syndrome Circulatory System

Interventions

Patients meeting the inclusion criteria will be approached for informed, written consent for the abbreviated research scan prior to their standard scan appointment. If they decline participation in th

Sponsors

University Hospitals of Leicester NHS Trust
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Aortic stenosis cohort: 1. Provision of written informed consent 2. Known aortic stenosis of any degree 3. Must have had a prior baseline minimum standard echocardiogram dataset (BSE) at least 6 months ago 4. Outpatient or inpatient Acute coronary syndrome: 1. Provision of written informed consent 2. Inpatient admitted with ST-elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction (NSTEMI) or unstable angina defined by two or more of raised cardiac troponin, ECG changes and/or symptoms as per European Society of Cardiology definitions 3. Outpatient if post-discharge without having an IP transthoracic echocardiogram (TTE) 4. Include MI with non-obstructive coronary artery (MINOCA) 5. Pre- and post-angiography patients will be included 6. Patients deemed to have Takotsubo cardiomyopathy will also be included

Exclusion criteria

Exclusion criteria: Aortic stenosis: 1. Unwilling or unable to provide written consent 2. Patient with other significant pathology on baseline echo which needs re-assessment (other valve disease, cardiomyopathies, etc) 3. Patient with poor echo views 4. Adult congenital heart disease (exception of bicuspid aortic valve) Acute coronary syndrome cohort: 1. Unwilling or unable to provide written consent 2. Heart failure as primary diagnosis 3. Patients with known at least moderate severity of valve disease

Design outcomes

Primary

MeasureTime frame
Safety measured using the severity of disease as assessed in the report of the abbreviated protocol against the full report as gold standard. The number of missed other pathologies will also be assessed. Overall agreement, sensitivity and specificity of the abbreviated protocols will be measured statistically. All data will be measured at a single timepoint after the recruitment and once all data has been collected.

Countries

England, United Kingdom

Contacts

Public ContactPooja Raithatha
pooja.raithatha@nhs.net+44 (0)116 258 8054

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Aug 25, 2026